Patent: 4,820,805
✉ Email this page to a colleague
Summary for Patent: 4,820,805
| Title: | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
| Abstract: | A mammalian blood protein-containing composition such as whole blood, plasma, serum, plasma concentrate, cryoprecipitate, cryosupernatant, plasma fractionation precipitate or plasma fractionation supernatant substantially free of hepatitis and other lipid coated viruses with the yield of protein activity to total protein being at least 80% is disclosed. The protein-containing composition is contacted with di- or trialkylphosphate, preferably a mixture of trialkylphosphate and detergent, usually followed by removal of the di- or trialkylphosphate. |
| Inventor(s): | Alexander R. Neurath, Bernard Horowitz |
| Assignee: | New York Blood Center Inc |
| Application Number: | US06/726,200 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,820,805
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAPLAS | pooled plasma (human), solvent/detergent treated | For Injection | 125416 | January 17, 2013 | ⤷ Start Trial | 2006-04-11 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
